iMiCROQ obtains € 1.2 million to develop an automated device that integrates rapid detection of pathogens, DNA and food allergens
iMiCROQ has raised 1.2 million euros of European funds to develop the first platform that combines in a single solution different tests to detect pathogens, DNA, viruses, allergens and mycotoxins in food.Read more
iMiCROQ is pleased to communicate to all its customers, suppliers and personnel in general that we have agreed with PALEX Medical S.A. the exclusive distribution for Spain and Portugal of our portfolio of QFast products in agro-food safety.Read more
iMICROQ team has a large experience in participating in R&D national and european projects and will be a very good and reliable partner to collaborate with for H2020 projects.
We interested in joining to a partnership for Horizon 2020 research program.Read more
The Spanish company iMiCROQ, based in Tarragona, has recently closed a 1.5 M € capital increase round led by the SUEZ Group through its investment fund VENTO (Programa Innvierte in co-investment with CDTI) and the fund Caixa Innvierte Industria of Caixa Capital Risc. In this capital increase has also participated its traditional investors Valtari, Somtobir and Sider.Read more